Key Market Indicators
Sales of digestive system disorder medication in Canada are set to reach $4.2 billion by 2026. In 2021, the market was worth $3.9 billion, and has grown an average of 1.2% every year since 2017. Canada was the fourth largest market for digestive system disorder medication in 2021, with South Korea overtaking to reach $3.9 billion. Japan, South Korea, and Canada were the number 2, 3, and 4 spots, respectively.